American Healthcare REIT (AHR) Stock: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$50.88
0.19 (0.36%)
▲
5d:
-2.2%
30d:
-9.49%
90d:
-5.49%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.20
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$29.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $50.88, which is considered oversold relative to its 30-day fair value range of $51.81 to $55.69. From a valuation perspective, the stock is trading at a discount (Forward PE: 51.2) compared to its historical average (59.9). Remarkably, the market is currently pricing in an annual earnings decline of 5.1% over the next few years. This pessimistic expectation contrasts with the company's recent 157.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is currently testing key support at $50.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AHR scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $64.40 (+27.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is currently testing key support at $50.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AHR scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $64.40 (+27.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$51.81 -
$55.69
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (61/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.0% below Wall St target ($64.40)
- CAUTION: Bottoming setup, but lagging the sector by 22% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$51.81 -
$55.69
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$50.36
Resistance Level
$53.15
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
51.20
Wall Street Target
$64.40
(+27.0%)
Revenue Growth (YoY)
24.7%
Earnings Growth (YoY)
157.5%
Profit Margin
4.8%
Valuation Discount vs History
-5.1% cheaper
PE vs Historical
51.2 vs 59.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.1%
(market-implied from PE analysis)
1-Year Target
$48.10
(-5%)
2-Year Target
$45.65
(-10%)
3-Year Target
$43.32
(-15%)
3-Yr Target (if PE normalizes)
(PE: 51→60)
$50.68
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 51.2, Growth: 63.8%)
$171.08
(+238%)
Base:
(SPY PE: 20.4, Growth: 63.8%)
$68.16
(+35%)
Bear:
(PE: 17.3, Growth: 63.8%)
$57.94
(+14%)
📈
Valuation based on Current Earnings
Forward PE: 48.08 | Forward EPS (Implied): $1.05
Bull Case
$61.21
(+21%)
Analyst growth 15.0%, PE expands to 50.5
Base Case
$50.69
(0%)
Market implied 0.0%, PE stable at 48.1
Bear Case
$38.78
(-24%)
Severe decline -15.0%, PE contracts to 43.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 51.2 to 59.9
Stabilization Target:
$59.30
(+17.0%)
PE Expansion Potential:
+17.0%
Share & Embed Analysis
Last updated: October 02, 2026 3:16 PM ET
Data refreshes hourly during market hours. Next update: 4:16 PM
Data refreshes hourly during market hours. Next update: 4:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$102 | 58 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$262 | 61 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$23 | 46 HOLD |
|
OHI
Omega Healthcare Investo… |
HOLD
16 analysts |
$52 | 59 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
9 analysts |
$45 | 57 HOLD |
